• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

T1-T2期声门癌的放射治疗:各种治疗参数对局部控制/并发症的影响。

Radiation therapy in T1-T2 glottic carcinoma: influence of various treatment parameters on local control/complications.

作者信息

Dinshaw K A, Sharma V, Agarwal J P, Ghosh S, Havaldar R

机构信息

Department of Radiation Oncology, Tata Memorial Hospital, Mumbai, India.

出版信息

Int J Radiat Oncol Biol Phys. 2000 Oct 1;48(3):723-35. doi: 10.1016/s0360-3016(00)00635-0.

DOI:10.1016/s0360-3016(00)00635-0
PMID:11020569
Abstract

PURPOSE

To evaluate the influence of various treatment parameters on local control as well as complications in T1 and T2 glottic carcinomas.

METHODS AND MATERIALS

Between 1975 and 1989, 676 patients with early glottic carcinoma (460 T1 and 216 T2) received curative radiation with three different treatment regimens, as follows: Regimen 1-50 Gy/15 Fr/3 weeks (3.33 Gy/daily) for 192 patients; Regimen 2-60-62.5 Gy/24-25 Fr/5 weeks (2.5 Gy/daily) for 352 patients; and Regimen 3-55-60 Gy/25-30 Fr/5-6 weeks (2-2.25 Gy/daily) for 132 patients.

RESULTS

The local control at 10 years was 82% and 57% for T1 and T2 lesions respectively (p = 0.0). For the T1N0M0 group, field size had significant impact on local control with both univariate (p = 0.05) and multivariate (p = 0.03) analysis. For T2N0M0, group field size (p = 0.03) as well as registration year (p = 0.016) were significant in univariate analysis whereas only field size remained significant on multivariate analysis. Persistent radiation edema was noted in 146 (22%) patients and was significantly worse with larger field size (p = 0.000) but not related to different treatment regimens.

CONCLUSION

The shorter fractionation schedule had comparable local control, without increased complications in comparison to the protracted schedule and is best suited for a busy department.

摘要

目的

评估不同治疗参数对T1和T2声门癌局部控制及并发症的影响。

方法和材料

1975年至1989年间,676例早期声门癌患者(460例T1期和216例T2期)接受了三种不同治疗方案的根治性放疗,具体如下:方案1-192例患者接受50 Gy/15次分割/3周(每日3.33 Gy);方案2-352例患者接受60 - 62.5 Gy/24 - 25次分割/5周(每日2.5 Gy);方案3-132例患者接受55 - 60 Gy/25 - 30次分割/5 - 6周(每日2 - 2.25 Gy)。

结果

T1和T2病变10年局部控制率分别为82%和57%(p = 0.0)。对于T1N0M0组,单因素(p = 0.05)和多因素(p = 0.03)分析均显示照射野大小对局部控制有显著影响。对于T2N0M0组,单因素分析中照射野大小(p = 0.03)以及登记年份(p = 0.016)有显著意义,而多因素分析中仅照射野大小仍具有显著意义。146例(22%)患者出现持续性放射性水肿,照射野越大情况越严重(p = 0.000),但与不同治疗方案无关。

结论

与延长分割方案相比,短分割方案具有相当的局部控制率,且并发症未增加,最适合繁忙的科室。

相似文献

1
Radiation therapy in T1-T2 glottic carcinoma: influence of various treatment parameters on local control/complications.T1-T2期声门癌的放射治疗:各种治疗参数对局部控制/并发症的影响。
Int J Radiat Oncol Biol Phys. 2000 Oct 1;48(3):723-35. doi: 10.1016/s0360-3016(00)00635-0.
2
Influence of fraction size, total dose, and overall time on local control of T1-T2 glottic carcinoma.分次剂量、总剂量及总治疗时间对T1-T2期声门癌局部控制的影响。
Int J Radiat Oncol Biol Phys. 1997 Aug 1;39(1):115-26. doi: 10.1016/s0360-3016(97)00284-8.
3
Effect of radiation fraction size on local control rates for early glottic carcinoma. A model analysis for in vivo tumor growth and radio-response parameters.放射分次剂量对早期声门癌局部控制率的影响。体内肿瘤生长及放射反应参数的模型分析。
Arch Otolaryngol Head Neck Surg. 1994 Jul;120(7):737-42. doi: 10.1001/archotol.1994.01880310041008.
4
Radiation therapy for T1,2 glottic carcinoma: impact of overall treatment time on local control.T1、2期声门癌的放射治疗:总治疗时间对局部控制的影响。
Radiother Oncol. 1996 Sep;40(3):225-32. doi: 10.1016/0167-8140(96)01796-3.
5
Radiation therapy in early glottic carcinoma: uni- and multivariate analysis of prognostic factors affecting local control.早期声门癌的放射治疗:影响局部控制的预后因素的单因素和多因素分析
Int J Radiat Oncol Biol Phys. 1994 Dec 1;30(5):1059-64. doi: 10.1016/0360-3016(94)90310-7.
6
Results of radiotherapy for T2N0 glottic carcinoma: does the "2" stand for twice-daily treatment?T2N0声门癌的放射治疗结果:“2”代表每日两次治疗吗?
Int J Radiat Oncol Biol Phys. 2003 Feb 1;55(2):322-8. doi: 10.1016/s0360-3016(02)03938-x.
7
The impact of treatment time and smoking on local control and complications in T1 glottic cancer.治疗时间和吸烟对T1声门癌局部控制及并发症的影响。
Int J Radiat Oncol Biol Phys. 1998 Sep 1;42(2):247-55. doi: 10.1016/s0360-3016(98)00226-0.
8
Accelerated radiotherapy for T1, 2 glottic carcinoma: analysis of results with KI-67 index.T1、2期声门癌的加速放疗:基于KI-67指数的结果分析
Int J Radiat Oncol Biol Phys. 2000 Apr 1;47(1):81-8. doi: 10.1016/s0360-3016(00)00409-0.
9
Hyperfractionated accelerated radiotherapy for T1,2 glottic carcinoma. Consideration of time-dose factors.T1、2期声门癌的超分割加速放疗。时间剂量因素的考量。
Strahlenther Onkol. 2008 Jul;184(7):364-9. doi: 10.1007/s00066-008-1819-1. Epub 2008 Oct 1.
10
Impact of radiation therapy fraction size on local control of early glottic carcinoma.放射治疗分次剂量对早期声门癌局部控制的影响。
Int J Radiat Oncol Biol Phys. 1997 Feb 1;37(3):587-91. doi: 10.1016/s0360-3016(96)00578-0.

引用本文的文献

1
The Evolving Role of Stereotactic Body Radiation Therapy for Head and Neck Cancer: Where Do We Stand?立体定向体部放射治疗在头颈癌治疗中不断演变的作用:我们目前的状况如何?
Cancers (Basel). 2023 Oct 16;15(20):5010. doi: 10.3390/cancers15205010.
2
Three-week hypofractionated radiotherapy in early glottic cancer-a single institution retrospective study.早期声门癌的三周超分割放疗——单机构回顾性研究
Ecancermedicalscience. 2022 May 4;16:1381. doi: 10.3332/ecancer.2022.1381. eCollection 2022.
3
Vocal-cord Only vs. Complete Laryngeal radiation (VOCAL): a randomized multicentric Bayesian phase II trial.
仅声带 vs. 全喉放疗(VOCAL):一项随机多中心贝叶斯Ⅱ期试验。
BMC Cancer. 2021 Apr 22;21(1):446. doi: 10.1186/s12885-021-08195-8.
4
Outcome of Early-Stage Glottic Laryngeal Carcinoma Patients Treated with Radical Radiotherapy Using Different Techniques.采用不同技术进行根治性放疗的早期声门型喉癌患者的治疗结果
J Oncol. 2019 Nov 6;2019:8640549. doi: 10.1155/2019/8640549. eCollection 2019.
5
Hypofractionated radiotherapy for early glottic cancer: a retrospective interim analysis of a single institution.早期声门癌的大分割放疗:单机构回顾性中期分析
Radiat Oncol J. 2019 Jun;37(2):82-90. doi: 10.3857/roj.2019.00143. Epub 2019 Jun 30.
6
Conventional fractionation should not be the standard of care for T2 glottic cancer.对于 T2 声门型喉癌,常规分割放疗不应作为标准治疗。
Radiat Oncol. 2017 Nov 14;12(1):178. doi: 10.1186/s13014-017-0915-8.
7
Evaluation of acute/late toxicity and local recurrence in T1-T2 glottic carcinoma treated with accelerated hypofractionated 3D-conformal external beam radiotherapy (3D-CRT).评估 T1-T2 声门型喉癌采用加速超分割三维适形外照射放疗(3D-CRT)治疗后的急/晚期毒性和局部复发情况。
Radiol Oncol. 2013 May 21;47(2):185-91. doi: 10.2478/raon-2013-0020. Print 2013 Jun.
8
Evaluation of lasersurgery and radiotherapy as treatment modalities in early stage laryngeal carcinoma: tumour outcome and quality of voice.评估激光手术和放射疗法作为早期喉癌的治疗方式:肿瘤转归和嗓音质量。
Eur Arch Otorhinolaryngol. 2013 Jul;270(7):2079-87. doi: 10.1007/s00405-013-2460-x. Epub 2013 Apr 9.
9
Multi-institutional analysis of early glottic cancer from 2000 to 2005.2000 年至 2005 年多机构早期声门型喉癌分析。
Radiat Oncol. 2012 Aug 1;7:122. doi: 10.1186/1748-717X-7-122.
10
Functional organ preservation in laryngeal and hypopharyngeal cancer.喉癌和下咽癌的功能性器官保留
GMS Curr Top Otorhinolaryngol Head Neck Surg. 2011;10:Doc02. doi: 10.3205/cto000075. Epub 2012 Apr 26.